• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.42% Nasdaq Up 0.45%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    33.21 Up 0.09(0.27%) 10:19AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:33.12
    Open:33.32
    Bid:33.16 x 100
    Ask:33.21 x 300
    1y Target Est:44.64
    Beta:1.32
    Next Earnings Date:30-Apr-15ACOR Earnings announcement
    Day's Range:32.81 - 33.38
    52wk Range:28.26 - 45.45
    Volume:44,378
    Avg Vol (3m):743,727
    Market Cap:1.41B
    P/E (ttm):79.07
    EPS (ttm):0.42
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ACOR

    Comparison

    Symbol% ChgMkt Cap
    ACORUp 0.27%1.41B
    BIIBDown 0.37%93.90B
    TEVADown 2.20%53.66B

    Key Statistics

    Forward P/E (1 yr):34.89
    P/S (ttm):3.45
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :0.53
    Quarterly EPS Est (Mar-15) :0.14
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):1.95

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback